PKM and neoplasm: Furthermore, mJPYZ can attenuate the delivery of exosomal PKM2 from tumor cells to macrophages, mitigate the M2‐TAM differentiation induced by exosomal PKM2 in the TME, and ultimately impede the progression of gastric cancer [22].